Comprehensive cancer care — from early detection to advanced treatment and rehabilitation.
As China's largest private oncology hospital group, HYGEIA offers a complete continuum of cancer care services powered by expert physicians, proprietary technology, and a patient-first philosophy.
Multi-disciplinary cancer care covering diagnosis, chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and palliative care. Integrated treatment plans tailored to each patient's specific cancer type, stage, and personal needs.
HYGEIA's self-developed Gyro Knife stereotactic radiotherapy system delivers precise radiation to head and body tumors. Our vertical integration ensures superior quality and significant cost advantages.
Minimally invasive and complex cancer surgeries performed by experienced surgical oncologists. Advanced techniques including laparoscopic, thoracoscopic, and robotic-assisted procedures.
Comprehensive cancer screening programs using advanced imaging and laboratory diagnostics. Early detection packages designed for international patients seeking peace of mind.
Our multi-disciplinary oncology teams have extensive experience treating a wide range of cancer types at all stages.
Comprehensive care for NSCLC and SCLC including targeted therapy, immunotherapy, and advanced radiotherapy.
HCC treatment combining interventional therapy, targeted drugs, radiotherapy, and surgical options.
Integrated approach with endoscopic resection, surgery, chemotherapy, and targeted therapy.
Multi-modal treatment from early-stage endoscopic removal to advanced metastatic management.
Breast-conserving surgery, radiotherapy, endocrine therapy, and targeted treatment for all subtypes.
Gyro Knife stereotactic radiosurgery and multidisciplinary management of primary and metastatic brain tumors.
Surgery, radiotherapy (including brachytherapy), and chemotherapy for all stages.
Precision radiotherapy, surgery, and combined modality treatment for complex head and neck malignancies.
Treatment for leukemia, lymphoma, and multiple myeloma with chemotherapy, targeted therapy, and immunotherapy.